BME 471 — Pharmaceutical Quality Systems

Condensed Study Notes for Exam Preparation

1. Quality Metrics

Introduced by US-FDA to monitor pharmaceutical manufacturing quality. A Quality Key Performance Indicator (Q-KPI)
— objective, data-based, and aligned with quality goals.

Key Metrics to Know:

Metric What it tracks

Batch Failure Rate % of batches failing release — waste & shortage risk

Deviation Rate & Cycle Time Manufacturing irregularities + investigation time

OOS Incidents Out-of-Specification test results → process drift

CAPA KPIs Corrective/Preventive Action closure rate, effectiveness

Complaint Rate Customer/adverse events per unit sold

Supplier Metrics Defect rate, on-time delivery, right-first-time

Yield / FPY First-Pass Yield — units passing without rework

Cost of Quality (CoQ) Internal failures (rework) + external failures (recalls)

OEE & Throughput Equipment effectiveness = uptime × performance × quality

■ Mnemonic: B-D-O-C-C-S-Y-C-O → Bad Dogs Often Create Complaints; Suppliers Yield Costly Overtime (Batch,
Deviation, OOS, CAPA, Complaint, Supplier, Yield, CoQ, OEE)

2. Operational Excellence (OpEx)

A systematic approach to optimizing pharma processes for efficiency, compliance, and continuous improvement.

Why It Matters (5 reasons):

• Regulatory Compliance — meets FDA, EMA, ICH guidelines
• Patient Safety — ensures safe, reliable products
• Cost Efficiency — reduces waste and operational costs
• Faster Time-to-Market — streamlined supply chain
• Competitive Advantage — innovation and service levels

Key Methodologies:
• Lean Thinking — eliminate waste (tools: 5S, Kaizen, Value Stream Mapping)
• Six Sigma (DMAIC) — Define, Measure, Analyze, Improve, Control → reduce defects
• TQM — Total Quality Management → long-term customer satisfaction
• Industry 4.0 — AI, IoT, automation for process optimization
• KPIs — proactively identify bottlenecks

■ Mnemonic: Lean Six Sigma TKI → 'Lean Six Tigers Kill Inefficiency' (Lean, Six Sigma, TQM, KPIs, Industry 4.0)

3. Quality Management Review (QMR)

A formal, documented assessment conducted at defined intervals to evaluate QMS performance, suitability, and
effectiveness. Required by ISO 9001, ISO 13485, 21 CFR Part 820, ICH Q10.

6 Steps to Conduct a QMR:

 • 1. Preparation & Planning — define scope, objectives, agenda, participants
• 2. Data Collection & Analysis — gather audit results, CAPA data, KPIs, complaints
• 3. Review Meeting — present data, discuss risks, assess resources
• 4. Action Items & Follow-up — document decisions, assign responsibilities, set timelines
• 5. Documentation & Reporting — formal QMR report, meeting minutes, action trackers
• 6. Implement Improvement Actions — execute updates, verify via CAPA/change control

■ Mnemonic: P-D-M-A-D-I → 'Pharma Docs Must Always Document Improvements'

QMR Inputs (what goes IN):

Audit results • Nonconformances • CAPA status • Customer complaints • Product/process performance • Resource
adequacy • Regulatory updates • Risk management data

QMR Outputs (what comes OUT):

Updated quality objectives • Improvement actions • Resource allocation decisions • Process/system updates • Assigned
responsibilities • Follow-up plans

QMR Frequency — When to review more often:

• High business complexity, high risk/compliance issues, frequent process changes
• Significant audit findings → trigger unscheduled review
• Post-market feedback trends, organizational growth
■ Key Point: Standards typically require annual or semi-annual QMRs.

Who is Responsible?

Role Responsibility

Top Management Overall accountability, approves actions, allocates resources

QA / QMR Representative Plans, schedules, compiles data, tracks actions to closure

Functional/Process Owners Provide KPIs, audit data, CAPA status

Regulatory Affairs (RA) Advises on regulatory changes and compliance risks

Document Control Maintains records, version control, retention

4. WHO-GMP Requirements

GMP (Good Manufacturing Practice) = the part of Quality Assurance ensuring products are consistently produced
and controlled to quality standards appropriate for their intended use.
■ Key Point: cGMP = current GMP. GMP is also a legal requirement covering distribution, contract manufacturing, and handling
defects/complaints.

The 10 Principles of WHO-GMP:

• 1. Written Procedures — detailed SOPs for every quality-affecting process
• 2. Facilities & Equipment — properly designed, maintained, calibrated, validated
• 3. Materials — tested quality, clearly identified, traceable (ingredients + containers)
• 4. Production — defined, controlled, validated manufacturing processes
• 5. Quality Control — testing at different stages (identity, purity, potency, quality)
• 6. Documentation — clear, accurate records retained and available for review
• 7. Personnel — qualified, adequately trained staff for each role
• 8. Validation & Change Control — changes reviewed, validated, and documented
• 9. Complaints & Recalls — systems for investigating complaints and taking corrective action
• 10. Auditing — regular self-inspections and quality audits to ensure GMP compliance
■ Mnemonic: WFM-PQD-PVC-A → easier as a story: 'Well-Fed Manufacturers Produce Quality Drugs; People
Validate Changes Annually' (Written, Facilities, Materials, Production, QC, Documentation, Personnel, Validation,
Complaints, Auditing)

Why GMP Matters (quick list):

• Product quality → safe, pure, effective medicines
• Prevent errors & contamination
• Regulatory compliance (WHO, FDA)
• Build trust, enable export
• Reduce costs and recalls

5. QC Standards: BP, USP, and SPC

A. British Pharmacopoeia (BP)

Published by MHRA (UK). Official quality standards for pharmaceutical materials — ensures safety, purity, and efficacy
of medicines.

Scope of BP:
• Drug substances (APIs): identity, purity, assay
• Dosage forms: tablets, capsules, injections, syrups
• Excipients: inactive ingredients (lactose, starch)
• Herbal products: plant-based medicines

Structure of a BP Monograph (remember: DITAT-ISL):

• Definition — description + content limits (% of active ingredient)
• Identification Tests — confirms the drug's identity
• Tests (Quality Tests) — purity, pH, impurities
• Assay — measures amount of active ingredient (potency)
• Impurities — limits for related substances/contaminants
• Storage Conditions — how the product must be stored
• Labeling Requirements — information required on packaging

■ Mnemonic: DITATS L → 'Doctors In Training Always Inspect Storage Labels'

BPCRS (BP Chemical Reference Substances):

Highly characterized reference materials used for calibration, method validation, identification of APIs and
impurities, and ensuring accuracy across labs.

B. United States Pharmacopeia (USP)

Legally recognized standards enforced by the FDA (USA). Ensures medicines meet requirements of Identity, Strength,
Quality & Purity.

Key Components:
• USP-NF — official compendium with 5000+ monographs, enforced by FDA
• Monographs — tests, methods, acceptance criteria for APIs/excipients/finished products
• Reference Standards — highly pure substances for accurate, reproducible testing
• General Chapters (<711>, etc.) — standardized procedures (e.g., dissolution testing)

Major USP QC Areas:

• Analytical procedures (HPLC, GC, spectrophotometry)
• Packaging & storage
 • Compounding standards
• Microbiological control (sterility testing)

C. BP vs USP — Key Differences:

Feature BP USP

Authority UK — MHRA USA — FDA

Coverage UK + Commonwealth USA + globally accepted

Pharmacopoeia link Aligned with European Ph. USP-NF (own compendium)

Chapter format General chapters (text) Numbered chapters <711>

Both include Monographs, general chapters, reference standards

D. Statistical Process Control (SPC)

A statistical method to measure, monitor, and control manufacturing processes by eliminating special cause variation.
Stresses prevention over detection.

SPC Benefits:
• Real-time error reduction
• Visibility into quality data — prevents over-tampering
• Control charts give operational insight to stakeholders
• Data accessibility levels the playing field

Control Charts (most important SPC tool — invented by Walter Shewhart, 1924):
A chart with plotted values, a central line (CL), Upper Control Limit (UCL), and Lower Control Limit (LCL). Used to
separate assignable (special) causes of variation from inherent (common) causes.

Two Categories of Control Charts:

• Variables Control Charts — for measurable data (weight, volume, temperature, pressure). Types: X-bar R chart,
X-bar S chart, Median-R chart.
• Attribute Control Charts — for countable/pass-fail data (defects, non-conforming units).

Control Chart Functions (6):

• Monitor process performance over time
• Describe what control there is
• Verify results of corrective actions
• Signal when corrective action is needed
• Estimate process capability
• Detect change in process performance

■ Mnemonic: M-D-V-S-E-D → 'Managers Daily Verify Systems, Estimate Drift'

Chart Preparation Steps:

• Step 1: Management prepares a responsive environment
• Step 2: Understand the process to be studied
• Step 3: Minimize unnecessary variation
• Step 4: Determine characteristics to control
• Step 5: Define the measurement system

BME 471 | BUET Biomedical Engineering | July 2025 Term